Total Funding
45
54
Total FundingVenture - Series Unknown raised
Growth Score
-7 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
41635
Indapta Therapeutics is a privately held biotechnology company.
- Moya Daniels: SVP, Regulatory Affairs and Clinical OperationsPast Role: Aruvant, Senior Vice President of Regulatory Affairs and Quality Assurance
- Guy DiPierro: Chief Operating Officer & FounderPast Role: Chrono Therapeutics, Founder, Chief Business Officer & SVP
About the Company
Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
